These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16320397)

  • 1. Devilish decline.
    Robertson H
    Curr Biol; 2005 Nov; 15(21):R858-9. PubMed ID: 16320397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Researching the Tasmanian devil facial tumour.
    Harington JS
    Aust Vet J; 2006 May; 84(5):N26. PubMed ID: 16739522
    [No Abstract]   [Full Text] [Related]  

  • 3. Wildlife biology. A devil of a disease.
    Bostanci A
    Science; 2005 Feb; 307(5712):1035. PubMed ID: 15718445
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.
    Murchison EP; Schulz-Trieglaff OB; Ning Z; Alexandrov LB; Bauer MJ; Fu B; Hims M; Ding Z; Ivakhno S; Stewart C; Ng BL; Wong W; Aken B; White S; Alsop A; Becq J; Bignell GR; Cheetham RK; Cheng W; Connor TR; Cox AJ; Feng ZP; Gu Y; Grocock RJ; Harris SR; Khrebtukova I; Kingsbury Z; Kowarsky M; Kreiss A; Luo S; Marshall J; McBride DJ; Murray L; Pearse AM; Raine K; Rasolonjatovo I; Shaw R; Tedder P; Tregidgo C; Vilella AJ; Wedge DC; Woods GM; Gormley N; Humphray S; Schroth G; Smith G; Hall K; Searle SM; Carter NP; Papenfuss AT; Futreal PA; Campbell PJ; Yang F; Bentley DR; Evers DJ; Stratton MR
    Cell; 2012 Feb; 148(4):780-91. PubMed ID: 22341448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
    Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
    Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission dynamics of Tasmanian devil facial tumor disease may lead to disease-induced extinction.
    McCallum H; Jones M; Hawkins C; Hamede R; Lachish S; Sinn DL; Beeton N; Lazenby B
    Ecology; 2009 Dec; 90(12):3379-92. PubMed ID: 20120807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tasmanian devil facial tumour disease: lessons for conservation biology.
    McCallum H
    Trends Ecol Evol; 2008 Nov; 23(11):631-7. PubMed ID: 18715674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
    Hollings T; Jones M; Mooney N; McCallum H
    Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-induced decline of an apex predator drives invasive dominated states and threatens biodiversity.
    Hollings T; Jones M; Mooney N; McCallum H
    Ecology; 2016 Feb; 97(2):394-405. PubMed ID: 27145614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Decades of the Impact of Tasmanian Devil Facial Tumor Disease.
    Woods GM; Fox S; Flies AS; Tovar CD; Jones M; Hamede R; Pemberton D; Lyons AB; Bettiol SS
    Integr Comp Biol; 2018 Dec; 58(6):1043-1054. PubMed ID: 30252058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transmissible cancer shifts from emergence to endemism in Tasmanian devils.
    Patton AH; Lawrance MF; Margres MJ; Kozakiewicz CP; Hamede R; Ruiz-Aravena M; Hamilton DG; Comte S; Ricci LE; Taylor RL; Stadler T; Leaché A; McCallum H; Jones ME; Hohenlohe PA; Storfer A
    Science; 2020 Dec; 370(6522):. PubMed ID: 33303589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allograft theory: transmission of devil facial-tumour disease.
    Pearse AM; Swift K
    Nature; 2006 Feb; 439(7076):549. PubMed ID: 16452970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endangered species: time to raise the devil.
    Dennis C
    Nature; 2006 Feb; 439(7076):530. PubMed ID: 16452951
    [No Abstract]   [Full Text] [Related]  

  • 16. Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy.
    O'Neill ID
    Int J Cancer; 2010 Oct; 127(7):1637-42. PubMed ID: 20473867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of disease on the survival and population growth rate of the Tasmanian devil.
    Lachish S; Jones M; McCallum H
    J Anim Ecol; 2007 Sep; 76(5):926-36. PubMed ID: 17714271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
    Deakin JE; Belov K
    Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex bias in ability to cope with cancer: Tasmanian devils and facial tumour disease.
    Ruiz-Aravena M; Jones ME; Carver S; Estay S; Espejo C; Storfer A; Hamede RK
    Proc Biol Sci; 2018 Nov; 285(1891):. PubMed ID: 30464069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.